Vendor, Beaverton, OR
Trace Biosciences Inc.
UEI YGDTEJXJC9G8, CAGE 9HEB7
1 award and $3,619,794 obligated between July 12, 2024 and July 16, 2025, 100% under full and open competition, against 2.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $3,619,794 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N91023C00042Definitive Contract, July 12, 2024, Full and Open Competition After Exclusion of Sources, 2 offers | NIH NCINational Institutes of Health | Purpose: 1) Change Cor Designation and 2) in Scope Change to Statement of Work.NAICS 541715, PSC AN13 | $3,619,794 |
- Places of performance
- Oregon
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 5 across 1 awards